Literature DB >> 24614092

Vestibular impairment in Charcot-Marie-Tooth disease type 4C.

Herminio Pérez-Garrigues1, Rafael Sivera2, Juan Jesús Vílchez3, Carmen Espinós4, Francesc Palau5, Teresa Sevilla3.   

Abstract

Charcot-Marie-Tooth disease type 4C (CMT4C) is a hereditary neuropathy with prominent unsteadiness. The objective of the current study is to determine whether the imbalance in CMT4C is caused only by reduced proprioceptive input or if vestibular nerve involvement is an additional factor. We selected 10 CMT4C patients and 10 age-matched and sex-matched controls. We performed a comprehensive evaluation of the vestibular system, including video Head Impulse Test, bithermal caloric test, galvanic stimulation test and skull vibration-induced nystagmus test. None of the patients experienced dizziness, spontaneous or gaze-evoked nystagmus, but all had significant vestibular impairment when tested when compared to controls. Seven had completely unexcitable vestibular systems and abnormal vestibuloocular reflex. There was no correlation between the degree of vestibulopathy and age or clinical severity. Significant vestibular impairment is a consistent finding in CMT4C and is present early in disease evolution. The profound imbalance that is so disabling in these patients may result from a combination of proprioceptive loss and vestibular neuropathy, and this would modify the recommended rehabilitation strategies. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  HMSN (CHARCOT-MARIE-TOOTH); NEUROPATHY; VERTIGO

Mesh:

Year:  2014        PMID: 24614092     DOI: 10.1136/jnnp-2013-307421

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  7 in total

1.  Vestibular impairment in Charcot-Marie-Tooth disease.

Authors:  Gülden Akdal; Koray Koçoğlu; Tural Tanrıverdizade; Elçin Bora; Fikret Bademkıran; Ayşe Nur Yüceyar; Özgül Ekmekçi; İhsan Şükrü Şengün; Hatice Karasoy
Journal:  J Neurol       Date:  2020-08-30       Impact factor: 4.849

2.  The influence of somatosensory and muscular deficits on postural stabilization: Insights from an instrumented analysis of subjects affected by different types of Charcot-Marie-Tooth disease.

Authors:  Tiziana Lencioni; Giuseppe Piscosquito; Marco Rabuffetti; Gabriele Bovi; Daniela Calabrese; Alessia Aiello; Enrica Di Sipio; Luca Padua; Manuela Diverio; Davide Pareyson; Maurizio Ferrarin
Journal:  Neuromuscul Disord       Date:  2015-05-11       Impact factor: 4.296

Review 3.  X-Linked Sensorineural Hearing Loss: A Literature Review.

Authors:  Virginia Corvino; Pasqualina Apisa; Rita Malesci; Carla Laria; Gennaro Auletta; Annamaria Franzé
Journal:  Curr Genomics       Date:  2018-08       Impact factor: 2.236

4.  The cerebellar phenotype of Charcot-Marie-Tooth neuropathy type 4C.

Authors:  Humberto Skott; Cristina Muntean-Firanescu; Kristin Samuelsson; Luca Verrecchia; Per Svenningsson; Helena Malmgren; Carmen Cananau; Alberto J Espay; Rayomand Press; Göran Solders; Martin Paucar
Journal:  Cerebellum Ataxias       Date:  2019-07-15

Review 5.  Selective Bilateral Vestibular Neuropathy in a Turkish CMT1B Family With a Novel MPZ Mutation.

Authors:  Gülden Akdal; Koray Koçoğlu; Elçin Bora; Altuğ Koç; Ayfer Ülgenalp; Mithat Bedir; Rahmi Tümay Ala; Esra Battaloğlu; Günay Kırkım; İhsan Şükrü Şengün; Gábor Michael Halmágyi
Journal:  Neurol Clin Pract       Date:  2021-04

Review 6.  Update on Cerebellar Ataxia with Neuropathy and Bilateral Vestibular Areflexia Syndrome (CANVAS).

Authors:  Mathieu Dupré; Ruben Hermann; Caroline Froment Tilikete
Journal:  Cerebellum       Date:  2020-10-04       Impact factor: 3.847

7.  A Chinese Patient with Spastic Paraplegia Type 4 with a De Novo Mutation in the SPAST Gene.

Authors:  Li Xu; Zijuan Peng; Chunhui Zhou; Jiqing Wang; Hunjin Luo; Qin Lu; Zhengjun Bao
Journal:  Case Rep Genet       Date:  2021-12-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.